Secretory meningioma
Open Access
- 15 May 1997
- Vol. 79 (10) , 2003-2015
- https://doi.org/10.1002/(sici)1097-0142(19970515)79:10<2003::aid-cncr23>3.0.co;2-x
Abstract
BACKGROUND Secretory meningioma is a rare histologic variant characterized by a unique epithelial differentiation of meningothelial cells resulting in the production of hyaline inclusions. Most previous reports have presented single case observations. The authors selected 31 cases for a clinicopathologic study to characterize this type of tumor further. METHODS Clinical data were compiled and the extent of peritumoral edema was assessed from preoperative computed tomography or magnetic resonance imaging scans. Preparations of surgical specimens of all tumors were studied after both conventional histologic and immunohistochemical preparations were made. Immunostaining was performed by either the avidin‐biotin complex method or the alkaline phosphatase‐antialkaline phosphatase method using 22 primary antibodies. RESULTS In the tumor collection used in this study, secretory meningiomas represented 3% of meningiomas. The female‐to‐male ratio was 9:1. Most tumors were located at the sphenoid ridge or at the frontal convexity, and recurrences were not observed. Eighty‐four percent of tumors presented with slight to marked peritumoral edema. The MIB‐1 staining index showed a mean of 3.8%. Inclusions and surrounding cells consistently expressed epithelial membrane antigen, cytokeratins, carcinoembryonic antigen, and carbohydrate antigen 19‐9. In decreasing frequency, they also contained α1‐antitrypsin, immunoglobulin (Ig)A, α1‐antichymotrypsin, IgM, and IgG. Cells positive for vimentin and S‐100 did not contain inclusions. All tumors were positive for progesterone receptors. Macrophages were stained with antibodies to factor XIIIa, human leukocyte antigen‐DR, and α1‐antitrypsin. In 64% of cases, tumor vessels lacked expression of glucose transporter protein 1. CONCLUSIONS The classification of secretory meningioma as a distinct variant has been justified on clinical, histologic, and immunohistochemical grounds. The unique epithelial features call attention to the broad spectrum of differentiation properties found in meningiomas. Cancer 1997; 79:2003‐15. © 1997 American Cancer Society.Keywords
This publication has 57 references indexed in Scilit:
- Cerebral edema in intracranial meningiomas: Evidence for local and diffuse patterns and factors associated with its occurrenceSurgical Neurology, 1994
- Peritumoral Edema in MeningiomasNeurosurgery, 1994
- Neural cyst of the ovary with central nervous system microvasculatureHistopathology, 1994
- Immunohistochemically demonstrated metallothionein expression in malignant melanomaHistopathology, 1993
- Tumor Prostaglandin Levels Correlate with Edema Around Supratentorial MeningiomasNeurosurgery, 1993
- Pattern of glucose transporter (Glut 1) expression in embryonic brains is related to maturation of bood‐brain barrier tightnessDevelopmental Dynamics, 1992
- The glucose transporter and blood-brain barrier of human brain tumorsAnnals of Neurology, 1990
- Immunohistological evaluation of macrophage infiltrates in brain tumorsJournal of Neurosurgery, 1988
- Meningothelial rosettes in the canine subarachnoid spaceActa Neuropathologica, 1985
- Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic featuresSurgical Neurology, 1983